(Bloomberg) – Tens of economic and political elites of Russia was to the people of early access to an experimental vaccine COVID-19, as familiar with the effort, as the country races to be among the first to develop a vaccine. The top executives of companies also in aluminum giant United Co. Rusal and billionaire tycoons and government officials began kicking the state Gamaleya Institute in Moscow, developed in April obtain, the people said. It sank to be identified because the information is not public. The vaccine Gamaleya, funded by the Russian State Fund Direct Investment and the Ministry of Defense, who last week got a Phase 1 trial of military personnel. The Institute for the study did not publish the results which involved about 40 people, but the next phase of testing with a larger group started. Gamaleya can press office did not immediately reached for comment are. Kremlin spokesman Dmitry Peskov, who won by COVID-19, after admitting with the virus in May for the hospital, said he did not know the name of those who have received the vaccine institute. Asked on a conference call with reporters on Monday, when President Vladimir Putin had made, Peskov said: “It would probably be a good idea to use a vaccine not certified on the head of state,” adding that he was not aware other officials seek. Peskov remarks followed a statement by the Ministry of Health that the only participants in tests for shots currently available Gamaleya into account. While new registrations are “safe” because the vaccines are based on other proven illnesses, their effectiveness is still has not been determined, according to Sergei Netesov, a former employee of the carrier, a state virology center of Novosibirsk, Siberia the also working on a vaccine. “Those who take it do so at their own peril,” said Netesov. Russia has more than 750,000 cases of COVID-19, the fourth largest total in the world, and Gamaleya of the program is on a faster track than most developers in the West. RDIF CEO Kirill Dmitriev said last week, phase 3 tests begin on August 3 and include thousands of people in Russia, Saudi Arabia and the United Arab Emirates, distributed with the vaccine nationwide in September. Western researchers typically run Phase 3 testing for months in order to better understand the safety and effectiveness. Gamaleya the candidate is called a viral vector vaccine based human adenovirus – a common cold virus – fused to the spike protein of SARS-CoV-2 to stimulate an immune response. And ‘it developed compared with a vaccine Cansino Biologics China that are already in Phase 2 studies with plans for more in Canada. Canada was among the countries – along with the United States and Britain – which last week the Russian government tries to hackers supported, its vaccine research accused of stealing secrets. Russian officials deny the charges. The program under the well-connected Russians the opportunity to volunteer for experimental vaccine doses is legal, potential participants were given, but always under lock and key to avoid a crush, a researcher familiar with the effort. He said that several hundred people were involved. Bloomberg confirmed dozens who have had the shots, but none would allow their names to be published. It is unclear how the participants will be selected, and are not part of official surveys, although they are monitored and the results announced by the Institute. Dmitriev of RDIF, he and his family told to take the shots and found that a significant number of other volunteers also have the option was given. He declined to give further details. The Gamaleya Institute said that their boss vaccinated, and teamwork on the process when it started. In May, state-controlled Sberbank recruited volunteers to take shots among employees. A senior executive who has been vaccinated said they experienced side effects. He said the health risks are worth it able to take a normal life, both personally and professionally. Customers have reported muscle pain and fever after getting the experience strokes. Several managers in Moskaueren offices of Rusal, which was based on Gamaleya Ebola vaccine are already using COVID-19 shots, people familiar with the matter said Institute has developed operations in the West African country of Guinea, to maintain it. is a manufacturer of fertilizers PhosAgro PJSC among the companies invited to follow other people. Spokesman PhosAgro and Rusal declined to comment. Some executives of large companies said they rejected the offer on health concerns. A mogul said he has not decided to participate after his doctor told him that it would take at least a year to evaluate the new risks of the vaccine. The first results of the study showed Cansino be adenovirus-based vaccine, a reduced effect on some people who had pre-existing immunity to this pathogen. RDIF the Dmitriev told investigators in Russia to test two different types of adenovirus vectors to reduce the chances of pre-existing immunity to reduce the effectiveness of cocktails. Chief Gamaleya Ginzbur Alexander said no knowledge of government officials or business leaders was to take its Vaccine Institute, according to Interfax. -With the help of Irina Reznik and Andrey Biryukov.
Report: The members of the Russian political and economic elite ‘are receiving Experimental COVID-19 vaccine
